//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts







Loading...
We can't wait to hear @leeat-keren.bsky.social insights on how spatial biology is unlocking new frontiers in cancer research. Abstract submission is closed but there is still time to register! Don’t miss it šŸ—“ June 28 – July 1, 2026 šŸ“Salt Lake City, Utah šŸ‘‰ metastasis-research.org/2024/06/26/m...
šŸ”¬ We are excited to welcome Dr. Kornelia Polyak @danafarber.bsky.social as a speaker at the upcoming #MRS2026 meeting! Registration is still open šŸ‘‰ metastasis-research.org/2024/06/26/m...
17d
23d
metastasis-research.org
2026 – MRS 21st Biennial Congress (Utah) | Metastasis Research
Metastasis Research Society
Metastasis Research Society
šŸ”¬ We are thrilled to welcome @leeat-keren.bsky.social (Weizmann Institute of Science) as a speaker at the upcoming #MRS2026 meeting! Registration is still open for #MRS2026! metastasis-research.org/2024/06/26/m...
Her recent work uncovered a critical epigenetic mechanism driving brain metastasis in triple-negative breast cancer, identifying KDM6A as a key mediator and potential therapeutic target šŸ“„ www.nature.com/articles/s41...
We can't wait to hear her insights on breast tumor evolution and the microenvironment. Abstract submission is closed but there is still time to register! Don't miss it! šŸ—“ June 28 – July 1, 2026 šŸ“ Salt Lake City, Utah šŸ‘‰ Register: metastasis-research.org/2024/06/26/m...
Dr. Polyak is a leader in breast cancer research and a pioneer in studying tumors as ecosystems. Her lab focuses on how the tumor microenvironment and intratumoral heterogeneity drive breast cancer evolution, from the earliest stages through metastatic, treatment-resistant disease.
Dr. Keren is a pioneer in spatial proteomics and multiplexed imaging, developing cutting-edge technologies to decode the tumor microenvironment at single-cell resolution. šŸ”— Keren Lab homepage: www.weizmann.ac.il/mcb/Keren/home
Her recent work is reshaping how we understand cancer progression: her lab showed that immune organization in sentinel lymph nodes of melanoma patients is prognostic of distant metastases, šŸ“„ Amitay et al., bioRxiv (2024): doi.org/10.1101/2024...
17d
23d
23d
23d
17d
17d
Seehawer et al. show that deletion of Kmt2c or Kmt2d promotes brain metastasis in mouse models of triple-negative breast cancer due to altered KDM6A activity and upregulated MMP3 expression, which may...
www.nature.com
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 - Nature Cell Biology
Human pathology is a result of complex processes that depend on the interplay between malignant cells, stroma, and the immune system, which can act both to suppress and promote various diseases, inclu...
www.weizmann.ac.il
doi.org
metastasis-research.org
labs.dana-farber.org
Home
2026 – MRS 21st Biennial Congress (Utah) | Metastasis Research
Home | Polyak Lab at Dana-Farber Cancer Institute
Metastasis Research Society
Metastasis Research Society
Metastasis Research Society
Metastasis Research Society
Metastasis Research Society
Metastasis Research Society